Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer
James P. Wilmot Cancer Center, Department of Medicine, University of Rochester, NY, USA.Breast Cancer Research and Treatment (Impact Factor: 3.94). 08/2008; 117(1):197-8. DOI: 10.1007/s10549-008-0074-6
Dear Editor, We describe here a patient with breast cancer who developed vitiligo in the cancer-affected breast and axilla during neoadjuvant chemotherapy. A 41-year-old premenopausal woman was diagnosed with clinical stage II breast cancer after she discovered a left breast mass. Physical examination revealed a freely mobile 3 cm mass in the left breast 12 o’clock position and an area of induration in the left axilla. There were no associated skin changes. Biopsy of the breast mass confirmed hormone-receptor positive, highgrade invasive ductal carcinoma. A fine needle aspiration of the left axillary lymph node was also positive for carcinoma. The patient had a history of intermittent vitiligo which was not evident on skin examination at the time of diagnosis of breast cancer. She was treated with 4 cycles of
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.